Sponsor or institution

Clinical trials and research at Dalin Tzu Chi General Hospital

As of November 12, 2026, Find a Trial lists 4 clinical trials run by Dalin Tzu Chi General Hospital that are recruiting, in Taiwan. By phase: Phase 2/3 (1), Phase 3 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest trials

StudyPhaseWhereStatusRegistered
Adding modulated electro‑hyperthermia to total neoadjuvant therapy for locally advanced rectal cancer Phase 3 Chiayi City, Dalin Township Recruiting Jan 28, 2026
Prune juice doses for constipation in older adults. — Chiayi City, Chiayi County Recruiting May 8, 2025
Pain management after cesarean section using Dinalbuphine Ester Phase 2/3 Dalin, Chai-Yi Recruiting Apr 3, 2024
Jing Si herbal tea for chronic pharyngolaryngitis — Chiayi City Recruiting Mar 26, 2024

All recruiting trials (4)

Quick answers

How many clinical trials run by Dalin Tzu Chi General Hospital are recruiting right now?

4, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

All of them have sites in Taiwan. Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.